Atypical Chronic Myeloid Leukemia (aCML) is a rare type of leukemia that occurs when the body produces too many white blood cells. Unlike traditional Chronic Myeloid Leukemia (CML), aCML is BCR/ABL-negative, meaning it does not have a specific genetic mutation commonly found in CML.
Despite its rarity, aCML is a serious condition that requires prompt medical attention. However, with proper treatment, many people with aCML can achieve remission, a state in which the cancer is undetectable through medical testing.
Common symptoms of aCML include:
It is important to note that these symptoms can also be caused by other conditions, so it is important to consult a doctor for a proper diagnosis.
Diagnosing aCML involves a series of tests, including:
These tests help doctors determine if a patient has aCML and what stage the cancer is in.
After initial treatment, some patients with aCML may achieve remission. This means that there is no evidence of cancer in the body. However, remission does not mean the cancer has been cured, and follow-up care is necessary to monitor for any possible recurrence.
Follow-up care may include regular blood tests, bone marrow biopsies, and imaging tests. Patients may also need to continue taking medication to prevent the cancer from returning.
Although aCML is a rare and serious condition, with proper treatment and follow-up care, many patients can achieve remission and live full, healthy lives. If you experience any symptoms of aCML, it is important to consult a doctor for a proper diagnosis and treatment plan.
Atypical chronic myeloid leukemia, BCR/ABL-negative, is a rare form of leukemia that affects the bone marrow. It is characterized by the overproduction of abnormal white blood cells, which can interfere with the normal functioning of the immune system. Although there is no cure for atypical chro...
To see full information about treatment please Sign up or Log in